Objective: Endocervical and endometrioid adenocarcinoma have marked overlapping features and the differentiation between them is important for their accurate management. Villin is an actin-binding protein which has an important role in the maintenance of microvilli in epithelial cells and epithelial cell-specific anti-apoptotic protein processes. Pro-Ex-C is a marker for higher-risk human papilloma virus (HPV) which targets the cell cycle proteins causing their overexpression. the aim of the study was to clarify the diagnostic and predictive role of villin, Pro-Ex-C, estrogen receptor (ER) and progesterone receptor (PR) expression in endocervical and endometrioid adenocarcinoma.
INTRODUCTION
Endocervical adenocarcinoma (ECa) is the 4 th most common cancer in females globally (1) and it has been ranked the 14 th most common cancer in Egyptian women between fifteen and forty-four years old (2) . Endometrioid adenocarcinoma (EMC) is the 6 th most common cancer in females globally (3) , and the 3 rd most common cause of female cancer-related mortality after cancers of the ovary and cervix (4) . EMC had accounted for 2.6% of total Egyptian female cancers (5) . ECa and EMC have significantly overlapping histopathological criteria and the differentiation between them both is important for their accurate management, as surgical excision of cancer and postoperative adjuvant chemo-and radio-therapy would depend on the primary site of origin of the carcinoma. ECa could be divided HPV-related ECas which include mucinous carcinoma with presence or absence of intestinal differentiation, serous and endometrioid carcinoma and HPV-unrelated subtypes which include mesonephric, clear cell, and gastric carcinomas (6) (7) (8) . Recent World Health Organization (WHO) tumors of Female Reproductive System Classification 2014 has included gastric subtype adenocarcinomas as a rare aggressive ECa subtype (9) . the differentiation between ECa and EMC could be difficult if the cancer involved the lower uterine segment or the upper endocervix. Even if hysterectomy specimens were taken, it would be difficult to detect the original site of the carcinoma (10) . Villin is an actin-binding protein which plays an important role in the maintenance of microvilli in epithelial cells and also has an essential role in the regulation of cell morphology and cell-specific epithelial anti-apoptotic mechanisms (11) . Villin is also expressed in intestinal metaplasia and is associated with Barrett's esophagus and chronic atrophic gastritis, but it was not expressed in normal gastric and esophageal tissues (12) . Villin is expressed in some adenocarcinomas but the absence of expression in normal epithelial tissues indicates a potential role in epithelial cell hyperplasia, dysplasia, or carcinogenesis (13) . Pro-Ex-C is a marker for HPV related cervical cancer and it targets cell cycle proteins like mini-chromosome maintenance protein-2 (MCM2), and topoisomerase II-a (tOP2a) which are overexpressed when viral DNa integrates into the host genome, leading to aberrant S-phase induction (14) . Many researchers have evaluated the use of estrogen receptor (ER) and progesterone receptor (PR) in distinguishing between ECa and EMC but the results have not been conclusive (15) . the aim of this study was to clarify the diagnostic panel of villin, Pro-Ex-C, ER and PR immunohistochemical expression in the differentiation between ECa and EMC and also to detect the predictive role of marker expression.
MATERIALS and METHODS

Patients Selection
Formalin-fixed, paraffin-embedded tissue blocks containing 15 cases of ECa and 30 cases of EMC were obtained retrospectively from the archives of the Department of Pathology, Faculty of Medicine, Zagazig University during the period between November 2010 and November 2015. Patient data such as age, tumor size, grade and stage were acquired from the archives. We used the International Federation of gynecology and Obstetrics' (FIgO) staging system for staging our cases (16) . We determined whether there was stromal invasion by carcinoma and classified such invasion by using recent patterns of stromal invasion (17, 18) .
Immunohistochemical Staining
Villin, Pro-Ex-C, ER and PR expressions were assessed using immunohistochemistry in sections from all the 45 blocks of paraffin. We analyzed correlations between the levels of Villin, Pro-Ex-C, ER and PR expressions and ability of panel of both markers in differentiation between ECa and EMC; we also analyzed the predictive role of marker expression. the streptavidine-biotin technique was used for immunohistochemical staining (19) . We incubated sections with primary; rabbit monoclonal antiPro-Ex-C-antibody (MCM2 26H6.19), mouse monoclonal anti-Villin-antibody (clone 1D2C3, ab739 , dilution 1:100) at 4°C overnight (abcam, Cambridge, Ma, USa), antiestrogen receptor (clone gF11, dilution 1:50, Novocastra Laboratories, Newcastle upon tyne, United Kingdom) and anti-progesterone receptor (clone 16, dilution 1:200, Novocastra), followed by incubation with secondary antibodies. Sections from small intestine were used as a positive control for villin, and sections from EMC were used as the positive control for ER and PR receptor expression (20, 21) . For negative controls, the primary antibodies were removed but replaced with phosphate-buffered saline. We evaluated the stained slides without previous identification of the clinical and pathological parameters.
Evaluation of Immunohistochemical Expression of Villin
We evaluated villin with either cytoplasmic and/or membranous staining, and scoring was according to the following criteria: 0 (not stained); one (membranous staining at less than 50% of the tumor cell); 2 (cytoplasmic staining and/or membranous expression at more than 50% of tumor tissues) (12) .
Evaluation of Immunohistochemical Expression of Pro-Ex-C
Pro-Ex-C staining was scored as negative when <5% nuclei were stained, diffuse positive when >80% of nuclei were stained (2), focal positive when 5% to 80% of nuclei were stained (22) .
Evaluation of Immunohistochemical Expression of ER and PR Receptors
Nuclear staining was scored by combining both the stain intensity and extent in tumor cells. Stain intensity was graded from zero (negative) to three (strong). the stain extent was graded as zero (negative expression), one (positive expression in less than ten percent of the tumor cells), two (positive expression in ten to fifty percent of the tumor cells) and three (positive expression in greater than 50% of the tumor cells). the final score (zero to nine) was reached by multiplying the staining intensity and extent scores. a final cut off staining score of less than four was interpreted as low expression and a score equal to or more than four was interpreted as high expression (23) .
Statistical Analysis
Validity of immunohistochemical markers in diagnosis of histopathological type was calculated using diagnostic performance depending on sample 2x2 contingency tables generation. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated. all tests were two sided. a p-value <0.05 was considered significant. We used SPSS 22.0 Windows (SPSS Inc., Chicago, USa) and MedCalc Windows (MedCalc Software bvba 13, Ostend, Belgium) for statistical analysis. Continuous variables were designated as mean ± SD and median (range); categorical variables were designated as numbers (percentage). We used Chi-square test for trend
Immunohistochemical Findings
the detailed immunohistochemical characteristics that were observed in ECa and EMC using villin, Pro-Ex-C, ER and PR are summarized in tables II-IV and illustrated in Figures 1a-E , 2a-D.
Villin Expression
Positive staining for villin was observed in 93.3% (14/15) of ECa cases; 12 showed diffuse expression, while the remaining 2 cases showed focal expression. On the other hand, focal positivity was found in 6 cases (20%) of EMC. the difference between villin expression in the two groups and the Independent samples Student's t-test for comparing the age between groups.
RESULTS
a total of 45 cases were studied; the cases included: 15 cases of ECa, NOS and 30 cases of EMC. the age of all patients ranged from 39 to 72 years; from 44 to 72 years for EMC cases and from 39 to 65 for ECa cases (table I) . there was one case with pattern a, two cases with pattern B (both patterns a and B were Stage I) and thirty-two cases with pattern C (stage II-IV). the types of stromal pattern invasion are detailed in table I. Continuous variables were expressed as mean ± SD and median (range); categorical variables were expressed as number (percentage). 
Pro-Ex-C Expression
Positive nuclear staining for Pro-Ex-C was observed in 86.7% (13/15) of ECa cases; 10 was diffuse expression, while the remaining 3 cases showed focal expression On the other hand, no diffuse positivity was found in EMC and focal positivity was found in 4 EMC cases (13.3%). the difference of Pro-Ex-C expression in the two groups of gynecological malignancy was statistically significant (p<0.001). Positive Pro-Ex-C expression in ECa was statistically significantly associate with the size of the tumor (p=0.008), the presence of lymph node metastases (p=0.003), the presence of cervical stromal invasion (p<0.001) and the pattern of stromal invasion (p=0.002). No significant correlations were found between Pro-Ex-C expression, grade FIgO clinical stage and the presence of distant metastases. the detailed IHC scoring of different patterns of stromal pattern invasion was as follows: pattern 
DISCUSSION
there is a marked morphologic similarity between ECa and EMC which leads to difficult differentiation on hematoxylin&eosin stained sections especially in small pre-operative or D&C samples. the differentiation between these two malignancies is essential for adequate management (24) .
Villin is an important component in the structure of cytoskeleton and can bind actin in a calcium-dependent manner (25) . It is an anti-apoptotic epithelial protein that plays an essential role in regulating cellular morphology, survival and migration (26 were ECa and the remaining one case was diagnosed as small cell carcinoma of cervix, while no case of EMC was villin-positive (11) . another study by Moll et al. showed results similar to ours in that positive villin staining was found in only in 4/11 EMC (27) . the predictive role of villin as well as correlation between villin expression and clinicopathological characteristics has been addressed in our study, and we found a significant association between villin expression, cancer size, presence and pattern of stromal invasion, and presence of nodal metastasis, therefore We found that positive Pro-Ex-C expression in ECa was significantly correlated with larger size of the tumor, the presence of lymph node metastases, and the presence and pattern of cervical stromal invasion which clarified that Pro-Ex-C expression had a predictive and prognostic role demonstrating the prognostic role of villin in addition to the studied role in differentiation between EaC and ECa in our study. However, the absence of significant correlations between villin expression, FIgO stage and presence of distant metastases in our study may be due to the small sample size and was in agreement with the report by Wang et al. that cells expressing villin migrate and form distant metastases more commonly than villin-negative cells (28) . Khurana and george reported that villin may be modified during metastasis (26) . However, al-Maghrabi et al. could not establish any association between villin expression and nodal metastasis and stated that villin expression was not able to predict nodal metastasis. In addition, there was no significant correlation between villin expression and tumor stage (29) . In our results, villin expression was significantly positively correlated with size in tumors with a size less than 4 cm in diameter compared to those of 4 cm or more, and this finding was in line with results of al-Maghrabi et al. in colorectal carcinoma (29) . all previous data that were in line with ours have highlighted the possible predictive and prognostic role of villin in addition to its diagnostic role that we studied here in our study.
Fletcher et al. introduced Pro-Ex-C as a new marker for cervical dysplasia and neoplasia (30) . In our current study, we have explored the diagnostic role of Pro-Ex-C in patients with that cancer in addition to its diagnostic role and this was in agreement with previous researchers that have suggested that Pro-Ex-C facilitates the detection of atypical cells that have developed from normal, reactive or other nonmalignant cells within a Pap cytology specimen (35) , and also that Pro-Ex-C is an essential marker for highgrade CIN that can confirm the diagnosis of high-grade CIN and detect cases of atypical squamous metaplasia (36) . thus, the use of Pro-Ex-C to select female patients at risk of cancer progression and who need treatment could improve patient outcome, help early diagnosis, and decrease patient anxiety (35) . the absence of significant correlations between Pro-Ex-C expression, FIgO stage and presence of distant metastases in our study may be due to the small sample size.
ER positive expression was found in all cases (100%) of EMC in this study but it was not detected in any of the ECa cases although immunostaining for ER is usually positive in ECa but our results may be related to testing a small number of cases (n=15 predictive roles of these markers in ECa and EMC. On the other hand we found no significant correlations between villin and Pro-Ex-C expression, FIgO stage and the presence of distant metastases, possibly due to the small sample size and inclusion of only ECa and EMC. We recommend conducting another study that will include a large number of patients to prove and highlight the predictive roles of marker expression in both carcinoma types. Due to the rarity of cervical adenocarcinoma subtypes, we have included only cases of cervical adenocarcinoma, NOS in our study and we have recommended conducting a future study on such subtypes to assess the relations between our marker expression pattern and aggressiveness of such subtypes. It is recommended to perform another study adding the more conventional markers such as p16 and vimentin to compare our results, sensitivity and specificity using larger sample size and all subtypes of ECa and EMC for adequate interpretation.
proliferation of normal cervical squamous epithelium, and this proliferation-related receptor status which is probably induced by HPV infection and is usually expressed in neoplastic cervical squamous cells (37) . Socolov et al. reported that well-differentiated EMC was ER-and PRpositive, so that ER-positive expression was significantly correlated with PR expression. Well-differentiated EMC (gI) in the studied group also showed a higher content of ER and PR compared to moderately-differentiated EMC (gII) (38) . Slightly different results were found by Esheba et al. who have demonstrated that some cases of uterine serous carcinoma showed focal strong staining for ProEx-C (2/4, 50%) and less ER and PR expression than usually found in EMC (31) . However, we have studied only EMC and Esheba et al. studied other subtypes so it is important to recognize the morphological pattern and specific subtype to avoid misdiagnosis as an endocervical primary based on strong Pro-Ex-C expression.
We have chosen such recent markers because they were found to be more sensitive than conventional markers, e.g. p16 and vimentin (32, 33) . Previous studies found that p16INK4a had failed in distinguishing ECa and its expression was also related to a carcinogenesis mechanism involving HPV infection. p16 expression was observed in (55%) 80% of ECa while it was positive in 20% of EMC, and was correlated with HPV infection these results were in keeping with the published data which have shown that p16 immunostaining has a sensitivity for HPV infectionrelated ECa (range 82-100%) (39), but was less specific than villin and Pro-Ex-C expressions. (40) In conclusion, highly specific biomarkers such as villin and Pro-Ex-C have the potential to improve the diagnostic accuracy in differentiating between EMC and ECa, NOS. Based on the above mentioned data, the optimal approach to distinguishing between ECa and endocervical adenocarcinomas, NOS would be to use Pro-Ex-C, a hormone receptor marker (ER or PR), and villin as this marker panel's expression had a sensitivity of 100% and a specificity of 100% which is higher than conventional markers like p16 and vimentin that lead to many conflicting results, lower sensitivity and specificity. We also found significant positive correlations between villin and ProEx-C expression, tumor size and grade, and presence and pattern of stromal invasion which highlighted the possible
